G
Georgia
From 1/23/06 "Newsweek"
Thick and thin
If you're one of the 4 million Americans who take blood thinners, the news that Israeli Prime Minister Ariel Sharon suffered a hemorrhagic stroke shortly after being put on anticoagulants may have you worried about your own risk of internal bleeding. In fact, about 5 percent of those on Coumadin (warfarin), the most commonly prescribed blood thinner, develop serious bleeding problems. "That's a very significant risk," says Dr. Andrew Schafer, president-elect of the American Society of Hematology. To minimize it, check your blood pressure regularly - high blood pressure "is the most important cause of devastating bleeding strokes," says Columbia University neurologist Dr. Stephan Mayer. Seek medical care if you experience unusual headaches or slurred speech - possible signs of bleeding into the brain (for more info, type "warfarin" into the search engine at medlineplus.gov). Finally, take heart: in the next few years, the FDA is expected to approve a new class of oral anticoagulants that are not only much safer than warfarin but more effective.
Thick and thin
If you're one of the 4 million Americans who take blood thinners, the news that Israeli Prime Minister Ariel Sharon suffered a hemorrhagic stroke shortly after being put on anticoagulants may have you worried about your own risk of internal bleeding. In fact, about 5 percent of those on Coumadin (warfarin), the most commonly prescribed blood thinner, develop serious bleeding problems. "That's a very significant risk," says Dr. Andrew Schafer, president-elect of the American Society of Hematology. To minimize it, check your blood pressure regularly - high blood pressure "is the most important cause of devastating bleeding strokes," says Columbia University neurologist Dr. Stephan Mayer. Seek medical care if you experience unusual headaches or slurred speech - possible signs of bleeding into the brain (for more info, type "warfarin" into the search engine at medlineplus.gov). Finally, take heart: in the next few years, the FDA is expected to approve a new class of oral anticoagulants that are not only much safer than warfarin but more effective.